Read More 2 minute read Analyst Ratings 13 Analysts Have This to Say About Constellation Brands By Benzinga Insights Today, 10:34 PM Over the past 3 months, 13 analysts have published their opinion on Constellation Brands (NYSE:STZ) stock. These analysts… STZ
Read More 1 minute read Analyst Ratings Initiation News Price Target Citigroup Initiates Coverage On Constellation Brands with Buy Rating, Announces Price Target of $265 By Benzinga Newsdesk Today, 10:34 PM Citigroup analyst Filippo Falorni initiates coverage on Constellation Brands (NYSE:STZ) with a Buy rating and announces Price Target of $265. STZ
Read More 1 minute read News ‘Market Share, Sales For U.S. Spirits Overtake Beer’s For First Time; Spirits Like Gin, Vodka, Overtake Beer’s U.S. Market Share’ – Reuters News By Happy Mohamed Today, 10:34 PM - U.S. Distilled Spirits Council BUD
Read More 1 minute read Dividends Earnings News Here’s How Much You Would Have Made Owning Constellation Brands Stock In The Last 15 Years By Benzinga Insights Today, 10:34 PM Constellation Brands (NYSE:STZ) has outperformed the market over the past 15 years by 9.59% on an annualized basis… STZ
Read More 1 minute read Analyst Ratings News Price Target Evercore ISI Group Maintains Outperform on Constellation Brands, Raises Price Target to $260 By Benzinga Newsdesk Today, 10:34 PM Evercore ISI Group analyst Robert Ottenstein maintains Constellation Brands (NYSE:STZ) with a Outperform and raises the price target from $250 to $260. STZ
Read More 1 minute read Analyst Ratings News Price Target JP Morgan Maintains Overweight on Constellation Brands, Lowers Price Target to $250 By Benzinga Newsdesk Today, 10:34 PM JP Morgan analyst Andrea Teixeira maintains Constellation Brands (NYSE:STZ) with a Overweight and lowers the price target from $267 to $250. STZ
Read More 20 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023 By Benzinga Insights Today, 10:34 PM Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics… AGTI
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Overweight on Constellation Brands, Lowers Price Target to $277 By Benzinga Newsdesk Today, 10:34 PM Morgan Stanley analyst Dara Mohsenian maintains Constellation Brands (NYSE:STZ) with a Overweight and lowers the price target from $298 to $277. STZ
Read More 1 minute read Analyst Ratings News Price Target UBS Maintains Buy on Constellation Brands, Lowers Price Target to $267 By Benzinga Newsdesk Today, 10:34 PM UBS analyst Peter Grom maintains Constellation Brands (NYSE:STZ) with a Buy and lowers the price target from $281 to $267. STZ
Read More 1 minute read Analyst Ratings News Price Target BMO Capital Maintains Outperform on Constellation Brands, Lowers Price Target to $265 By Benzinga Newsdesk Today, 10:34 PM BMO Capital analyst Andrew Strelzik maintains Constellation Brands (NYSE:STZ) with a Outperform and lowers the price target from $290 to $265. STZ